These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8141567

  • 1. In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.
    Khardori N, Nguyen H, Rosenbaum B, Rolston K, Bodey GP.
    Antimicrob Agents Chemother; 1994 Jan; 38(1):134-7. PubMed ID: 8141567
    [Abstract] [Full Text] [Related]

  • 2. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.
    Brown BA, Wallace RJ, Onyi GO, De Rosas V, Wallace RJ.
    Antimicrob Agents Chemother; 1992 Jan; 36(1):180-4. PubMed ID: 1317144
    [Abstract] [Full Text] [Related]

  • 3. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW, Piddock LJ, Li MS, Lyon D, Chan CY, Cheng AF.
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [Abstract] [Full Text] [Related]

  • 4. In vitro antimicrobial susceptibilities of Nocardia species.
    Khardori N, Shawar R, Gupta R, Rosenbaum B, Rolston K.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):882-4. PubMed ID: 8494385
    [Abstract] [Full Text] [Related]

  • 5. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T, Casals JB, Eng J.
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
    Swenson JM, Wallace RJ, Silcox VA, Thornsberry C.
    Antimicrob Agents Chemother; 1985 Dec; 28(6):807-11. PubMed ID: 4083863
    [Abstract] [Full Text] [Related]

  • 7. CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
    Barrett MS, Jones RN, Erwin ME, Koontz FP.
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2):169-71. PubMed ID: 1315233
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S, Ohama Y, Okazaki M, Nukui Y, Moriya K.
    BMC Infect Dis; 2017 Mar 07; 17(1):197. PubMed ID: 28270102
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
    Yang SC, Hsueh PR, Lai HC, Teng LJ, Huang LM, Chen JM, Wang SK, Shie DC, Ho SW, Luh KT.
    Antimicrob Agents Chemother; 2003 Jun 07; 47(6):1958-62. PubMed ID: 12760874
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
    Shen GH, Wu BD, Hu ST, Lin CF, Wu KM, Chen JH.
    Int J Antimicrob Agents; 2010 Apr 07; 35(4):400-4. PubMed ID: 20138481
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
    Wallace RJ, Dalovisio JR, Pankey GA.
    Antimicrob Agents Chemother; 1979 Nov 07; 16(5):611-4. PubMed ID: 526002
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW.
    Antimicrob Agents Chemother; 2002 Oct 07; 46(10):3164-7. PubMed ID: 12234839
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M, Rodriguez F, Villalba R, Benavente MC, Gonzalez AI.
    Chemioterapia; 1987 Dec 07; 6(6):431-3. PubMed ID: 3481302
    [Abstract] [Full Text] [Related]

  • 20. In Vitro Activities of Omadacycline against Rapidly Growing Mycobacteria.
    Shoen C, Benaroch D, Sklaney M, Cynamon M.
    Antimicrob Agents Chemother; 2019 May 07; 63(5):. PubMed ID: 30858221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.